Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease
- 1 November 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (17) , 1163-1170
- https://doi.org/10.1016/0002-9149(90)91092-k
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgeryThe American Journal of Cardiology, 1989
- Diagnostic value for coronary artery disease of chest pain during dipyridamole-thallium stress testingThe American Journal of Cardiology, 1988
- Predicting cardiac complications in patients undergoing non-cardiac surgeryJournal of General Internal Medicine, 1986
- Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: Comparison of oral and intravenous administration of dipyridamoleJournal of the American College of Cardiology, 1986
- Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery diseaseJournal of the American College of Cardiology, 1986
- Dipyridamole–Thallium-201 Scintigraphy in the Prediction of Future Cardiac Events after Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imagingAmerican Heart Journal, 1982
- Multifactorial Index of Cardiac Risk in Noncardiac Surgical ProceduresNew England Journal of Medicine, 1977
- The Role of Anesthesia in Surgical MortalityJAMA, 1961
- The Electrocardiogram in Population StudiesCirculation, 1960